C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151689 Method of killing target cells in harvested cell populations with one or more immuno-toxins
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151472 Trefoil factor (TFF) peptides (tricyclic peptides, e.g., TFF2 peptides), for increasing the viscosity of mucus layers; used for treating damaged or abnormal mucus layers, e.g. in the gastrointestinal tract, respiratory/urogential systems, eyes
10/17/2002	US20020151471 Factor VII glycoforms
10/17/2002	US20020151469 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151468 Low oxygen affinity mutant hemoglobins
10/17/2002	US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
10/17/2002	US20020151061 Transform cells; obtain nutrient broth, incubate with binding polypeptide, transforming cells, evaluate cells for transformation activity
10/17/2002	US20020151053 Generation of preferential cells in culture; generate nutrient broth, inoculate with cells, propagate, recover preferential cells
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151046 52871, a novel human G protein coupled receptor and uses thereof
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150969 Generating peptidyl prolyl cis-trans isomerases; obtain cell, transform with vector containing isomerase, express vector, evaluate activity of enzyme
10/17/2002	US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002	US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150595 Antigenic preparations and the isolation of such preparations
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150580 Administering genetic engineered antibody; binding to antigen; rheumatic diseases, skin disorders, autoimmune disease
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150571 Antibodies specific for native PrPSc
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150569 Using monoclonal antibodies
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150554 Chicken interleukin-15 and uses thereof
10/17/2002	US20020150552 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
10/17/2002	US20020150541 Mixture of human interferons; viricides; anticancer agents; antiinflammatory agents;
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443303A1 Method for preparing and selecting antibodies
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443277A1 Interferon gamma polypeptide variants
10/17/2002	CA2443275A1 Improved gene expression
10/17/2002	CA2442935A1 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2437073A1 Novel nucleic acids and polypeptides
10/17/2002	CA2433463A1 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/16/2002	EP1249456A1 Novel peptide and screening method by using the same
10/16/2002	EP1248855A2 Sequences characteristic of bladder cancer
10/16/2002	EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248804A2 Recombinant antibodies to human interleukin-1 beta
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248536A2 Porphyrin containing lactic acid bacterial cells and use thereof
10/16/2002	EP1248519A1 Expansion of stem and progenitor cells by beta-catenin
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1137935A4 Detection of preharvest sprouting in cereal grains
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0774001B1 Production of tissue factor pathway inhibitor
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	CN1375006A Novel compound
10/16/2002	CN1374970A Signal sequence for the productino of leu-hirudine via secretion by E coli in a culture medium
10/16/2002	CN1374870A Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody
10/16/2002	CN1374321A 肽载体 Peptide carrier
10/16/2002	CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/15/2002	US6465621 Polypeptides and polynucleotides of the gtp-binding protein family
10/15/2002	US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002	US6465249 Genetic engineering; controlling concentration in culture media
10/15/2002	US6465220 Glycosylation using GalNac-T4 transferase
10/15/2002	US6465216 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein
10/15/2002	US6465210 Nucleic acid molecules encoding CASPR/p190
10/15/2002	US6465209 Methods of producing protein hydrolysates
10/15/2002	US6465204 Amidase
10/15/2002	US6465194 Monoclonal antibodies to 4,4′-dinitrocarbanilide and a method for analyzing for the drug nicarbazin
10/15/2002	US6465184 Determining gene expression of nucleic acid encoding tumor rejection antigen precursors
10/15/2002	US6465181 Reagents and methods useful for detecting diseases of the prostate

1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 1125